to main content COVID Testing--Reporting | Ambulatory | Leadership LD | The Joint Commission
COVID Testing--Reporting

How will The Joint Commission evaluate the CMS reporting requirements for SARS-CoV-2 testing?

Any examples are for illustrative purposes only.

Effective October 15, 2020, The Joint Commission is only evaluating the reporting of SARS-CoV-2 test results in the Laboratory Accreditation Program. We continue to communicate with CMS to determine the impact of these new CLIA regulations on the other accreditation programs.  Joint Commission surveyors will review the documentation of SARS-CoV-2 test result reporting during the Regulatory Review session of the survey. Noncompliance with the new CLIA SARS-CoV-2 test reporting requirements will be documented at Standard LD.04.01.01, EP 2.

Please refer to the Guidance from the Department of Health and Human Services (HHS) for more information regarding additional requirements
Manual: Ambulatory
Chapter: Leadership LD
First published date: October 08, 2020 This Standards FAQ was first published on this date.
This page was last updated on October 29, 2021

If no, please comment on how we could improve this response.

If you have additional standards-related questions regarding this topic, please use the Standards Online Submission Form